Recurrent	recurrent	O	O	O	O
reversible	reversible	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
from	from	O	O	O	O
amphotericin	amphotericin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
patient	patient	O	O	O	O
with	with	O	O	O	O
cryptogenic	cryptogenic	O	O	O	O
cirrhosis	cirrhosis	O	DISEASE	OTHERS	I
and	and	O	O	O	O
disseminated	disseminated	O	O	O	O
sporotrichosis	sporotrichosis	O	O	OTHERS	I
developed	developed	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
immediately	immediately	O	O	O	O
following	following	O	O	O	O
the	the	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
amphotericin	amphotericin	CHEMICALS	O	OTHERS	I
B	b	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
four	four	O	O	O	O
separate	separate	O	O	O	O
occasions	occasions	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
abruptness	abruptness	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
and	and	O	O	O	O
its	its	O	O	O	O
reversibility	reversibility	O	O	O	O
within	within	O	O	O	O
days	days	O	O	O	O
suggests	suggests	O	O	O	O
that	that	O	O	O	O
there	there	O	O	O	O
was	was	O	O	O	O
a	a	O	O	O	O
functional	functional	O	O	O	O
component	component	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
dysfunction	dysfunction	O	DISEASE	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
propose	propose	O	O	O	O
that	that	O	O	O	O
amphotericin	amphotericin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
setting	setting	O	O	O	O
of	of	O	O	O	O
reduced	reduced	O	O	O	O
effective	effective	O	O	O	O
arterial	arterial	O	O	O	O
volume	volume	O	O	O	O
,	,	O	O	O	O
may	may	O	O	O	O
activate	activate	O	O	O	O
tubuloglomerular	tubuloglomerular	O	O	O	O
feedback	feedback	O	O	O	O
,	,	O	O	O	O
thereby	thereby	O	O	O	O
contributing	contributing	O	O	O	O
to	to	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

